首页 | 本学科首页   官方微博 | 高级检索  
     

以异环磷酰胺为主治疗晚期肺癌42例疗效观察
引用本文:张燕,王哲海,周登峰,张保轩,孙雅红,冯斌,陈黎. 以异环磷酰胺为主治疗晚期肺癌42例疗效观察[J]. 肿瘤基础与临床, 1999, 0(6)
作者姓名:张燕  王哲海  周登峰  张保轩  孙雅红  冯斌  陈黎
作者单位:山东省肿瘤防治研究院内二科
摘    要:目的 探讨以异环磷酰胺(IFO) 为主的化疗方案治疗晚期肺癌的疗效。方法 42 例晚期肺癌,SCLC组19 例,NSCLC组23 例,SCLC组以IE方案(IFO+ Vp -16) 、NSCLC组以IVP方案(IFO+ VDS+ PDD) 。结果 全组病人有5 例达CR,15 例达PR,总有效率(RR)40-47 % 。其中SCLC组RR 为63-15% ,NSCLC组RR为34-78 % 。本组毒性反应轻微。结论 以IFO为主的化疗方案治疗晚期肺癌疗效显著,毒性较小,可作为二线治疗方案。

关 键 词:异环磷酰胺  晚期肺癌  化疗

Combined Chemotherapy Containing Ifosfamide in the Treatment of Advanced Lung Cancer
Zhang Yan,Wang Zhehai,Zhou Dengfeng,et al. Combined Chemotherapy Containing Ifosfamide in the Treatment of Advanced Lung Cancer[J]. journal of basic and clinical oncology, 1999, 0(6)
Authors:Zhang Yan  Wang Zhehai  Zhou Dengfeng  et al
Affiliation:Zhang Yan,Wang Zhehai,Zhou Dengfeng,et al Department of Internal Medicine,Shanong Tumor Hospital,Jinan 250117 [
Abstract:Objective To study the therapeutic efficacy of the conbined chemotherapy containing infosfamide. Method All the 42 patieints with advanded lung cancer consist of 19 patieints with SCLC and 23 patients with NSCLC. The SCLC group was treated with the regimen consisting of ifosfamide plus Vp-16 and the NSCLC group was treated with the regimen of ifosformide, VDS and PDD. Result Five complete responses and fifteen partial responses were observed. The objective response was observed in 40.47% of patieints and 63.15% of patieints in the SCLC versus 34.78% in the NSCLC. The toxicity mild. Conclusion The therapeutic efficacy of conbined chemotherapy containing infosfamide in the treatmnet of advanced lung cancer is noticeable, the toxicity is mild and the regimen used secondly. [
Keywords:ifosofamide   advanced lung cancer   chemotherapy
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号